MURRAY RICHARD /CA/ (CEO and President) sold 16.5% of their position (45.07K shares) of JOUNCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $50.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/11/2023ACC: 0001640455-23-000010
DirectorOfficer· CEO and President
Since Sep 2018
-45.07K
Net shares
Net seller
$50.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
45.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20.19K
Price / share
$1.10
Trade value
$22.21K
% of position
7.4%
1/9/2023
273.08K→252.89K
Common Stock
Direct
Shares
−24.88K
Price / share
$1.12
Trade value
$27.86K
% of position
9.8%
1/10/2023
252.89K→228.01K
Total
Net shares
−45.07K
Net value
-$50.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2023 | S · Sale | −20.19K | $1.10 | $22.21K | 7.4% | 273.08K | 252.89K |
| Common Stock Direct | 1/10/2023 | S · Sale | −24.88K | $1.12 | $27.86K | 9.8% | 252.89K | 228.01K |
| Total | −45.07K | -$50.07K | ||||||
Derivative Transactions0
No derivative transactions reported